Global Neurodegenerative Disease Market Size, Share, and COVID-19 Impact Analysis, By Disease (Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Multiple Sclerosis), By Route of Administration (Oral, Injectable, Transdermal, and Others), By Drug (Cholinesterase Inhibitors, Gene Therapy, NMDA Receptor Antagonists, and Dopaminergic Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
Industry: Healthcare
Need help to buy this report?
Inquiry Before Buy